摘要
目的 探讨糖尿病合并侵袭性肺曲霉菌感染的临床诊断和治疗方法。方法 回顾性分析我院2015年1-10月收治的20例糖尿病合并侵袭性肺曲霉菌感染患者的临床治疗资料,均采用伏立康唑序贯治疗方法进行治疗,观察治疗效果。结果 治疗痊愈12例,痊愈率60%。出现肝功能损害1例,肠胃反应2例,皮疹1例,不良反应发生率20%,患者的并发症症状均通过临床治疗缓解并消失。结论 糖尿病合并侵袭性肺曲霉菌感染患者采用伏立康唑序贯疗法治疗,取得了良好的治疗效果,值得临床推广应用。
Objective To investigate the clinical diagnosis and treatment of invasive pulmonary Aspergillus infection in patients with diabetes mellitus. Methods The clinical data of 20 patients with invasive pulmonary Aspergillus infection treated in our hospital from January 2015 to October 2015 were analyzed. They were given adopt voriconazole sequential treatment, the treatment effect was observed. Results 12 cases were cured, the cure rate was 60%. There was 1 cases with liver function damage, 2 cases with gastrointestinal reaction, 1 cases with skin rash, the incidence of adverse reactions was 20%. The complications of the patients were relieved and disappeared by clinical treatment. Conclusion Diabetic patients with invasion of pulmonary Aspergillus infection patients treated with voriconazole sequential therapy, achieve a good therapeutic effect, it is worthy of clinical application.
出处
《中国继续医学教育》
2016年第14期139-140,共2页
China Continuing Medical Education
关键词
糖尿病
侵袭性肺曲霉菌感染
伏立康唑
临床疗效
Diabetes
Invasive pulmonary aspergillosis
Voriconazole
Clinical efficacy
